Company Profiles

driven by the PitchBook Platform

Akriveia Therapeutics

Description

Provider of immunotherapy treatment for cancer. The company provides a platform designed to address issues with immunotherapies by restricting the action of the therapeutic agent to just the site of the cancer.

2016

Founded

PRIVATE

Status

Series A

Latest Deal Type

$7.5M

Latest Deal Amount

$7.5M

Total Amount Raised

1

Investors

Description

Provider of immunotherapy treatment for cancer. The company provides a platform designed to address issues with immunotherapies by restricting the action of the therapeutic agent to just the site of the cancer.

Website:

www.akriveia-therapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Other Pharmaceuticals and Biotechnology

Primary Office

23 Southern Hills Drive Skillman, NJ 08558United States +1 (609) 560-0927
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Akriveia Therapeutics's full profile, request a free trial.

    Akriveia Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Akriveia Therapeutics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    F-Prime Capital PartnersVenture CapitalMinority000 0000000 0000
    F-Prime Capital Partners Venture Capital

    Akriveia Therapeutics Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Simon Tomlinson Ph.DChief Executive Officer and Board Member
    C. Glenn Begley Ph.DChief Scientific Officer
    John Williams Ph.DCo-Founder and Member of Scientific Advisory Board
    Ulrich Rodeck Ph.DCo-Founder and Member of Scientific Advisory Board
    Margret Karow Ph.DVice President, Drug Discovery and Preclinical Development
    Simon Tomlinson Ph.D Chief Executive Officer and Board Member
    C. Glenn Begley Ph.D Chief Scientific Officer
    John Williams Ph.D Co-Founder and Member of Scientific Advisory Board
    Ulrich Rodeck Ph.D Co-Founder and Member of Scientific Advisory Board
    Margret Karow Ph.D Vice President, Drug Discovery and Preclinical Development

    Akriveia Therapeutics Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Benjamin AuspitzAkriveia TherapeuticsBoard Member000 0000
    Jessica Alston Ph.DF-Prime Capital PartnersAssociate000 0000
    Simon Tomlinson Ph.DAkriveia TherapeuticsChief Executive Officer and Board Member000 0000
    Tiffany YuF-Prime Capital PartnersAnalyst000 0000
    Benjamin Auspitz Board Member Akriveia Therapeutics
    Jessica Alston Ph.D Associate F-Prime Capital Partners
    Simon Tomlinson Ph.D Chief Executive Officer and Board Member Akriveia Therapeutics
    Tiffany Yu Analyst F-Prime Capital Partners
    Request full access to PitchBook